Team

Luc Koldewyn graduated with a bachelors in biology from Colorado State University in 2009. He began his medical career as an assistant to Dr. E. Jeffrey Donner in 2009 with Rocky Mountain Associates in Orthopedic Medicine (RMA). Through his experience with RMA, he gained knowledge assisting several physicians in spine treatment, orthopedic treatments, interventional pain, manual manipulation, and regenerative medicine. Continuing education Luc was involved as an EMT, assisting in procedures and became more involved in the OR for spine procedures where he was a medical hardware representative.

Luc and Dr. Donner began development of the stem cell program in 2015 where they took their combined knowledge to develop the Elite Regenerative Stem Cell Specialists. Luc has been the program coordinator and assistant director, continuing the advancement of the business and science. Luc is active in the onsite medical laboratory, developing medical devices, and continued research in the field of regenerative medicine.

Luc has a personal connection with bio-cellular treatment. In 2011 he acquired an injury to his lower back while harvesting hay. The MRI indicated a 6mm herniation and degenerative disc disease. After conservative treatment failed, the only option was a lumbar fusion at L5-S1. He opted for a stem cell treatment which regenerated his disc and he has been pain free ever since.

Dr. Dregalla holds a Bachelor’s of Science in Microbiology and a Doctorate of Philosophy in Molecular & Cellular Biology from Colorado State University. Dr. Dregalla is an experienced creator of technologies in the biotechnology realm, most recently serving as the Senior Research Scientist of Regenerative Sciences, LLC where he designed elaborate research protocols to investigate the use of autologous stem cells for treatment of orthopedic ailments. Relevant scientific works that he has authored can be found in the National Center for Biotechnology Information and the National Library of Medicine. Additionally, these scientific findings have earned awards for excellence in research and invitations to present these findings at internationally research societies. Having spent multiple years in the start-up biotechnology and healthcare sector, Dr. Dregalla has developed a critical understanding of regulatory guidelines and recognizes the tremendous void which exists between medical applications and current advancements in science. At this time, Dr. Dregalla is creating a biotechnology company with the aim of applying molecular technologies and methodologies to make significant and necessary advancements in medical applications.